Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
20.65
+0.18 (0.88%)
Nov 22, 2024, 4:00 PM EST - Market closed

Genmab Market Cap

Genmab has a market cap or net worth of $13.13 billion as of November 22, 2024. Its market cap has decreased by -32.66% in one year.

Market Cap
13.13B
Enterprise Value
10.86B
1-Year Change
-32.66%
Ranking
Category
Stock Price
$20.65

Market Cap Chart

Since April 23, 2012, Genmab's market cap has increased from $420.50M to $13.13B, an increase of 3,023.30%. That is a compound annual growth rate of 31.45%.

History

DateMarket Cap% Change
Nov 20, 202413.53B-35.71%
Dec 29, 202321.04B-24.60%
Dec 30, 202227.90B7.47%
Dec 31, 202125.96B-1.89%
Dec 31, 202026.46B84.27%
Dec 31, 201914.36B35.31%
Dec 31, 201810.61B-0.44%
Dec 29, 201710.66B-0.04%
Dec 30, 201610.66B23.74%
Dec 31, 20158.62B128.70%
Dec 31, 20143.77B49.72%
Dec 31, 20132.52B179.56%
Dec 31, 2012900.30M114.10%
View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Incyte 13.56B
Revvity 13.52B
DaVita 13.46B
Insmed 13.20B
Universal Health Services 13.04B
Fresenius Medical Care AG 12.75B
Neurocrine Biosciences 12.66B
BioMarin Pharmaceutical 12.09B
Market Cap Rankings